Prognostic Impact of Nectin4 and IRF6 Expression in Patients Undergoing Radical Cystectomy for Muscle-Invasive Bladder Cancer
Cancer Diagnosis & Prognosis · 01.11.2026 · 6 (6) · 947-960
DOI: 10.21873/cdp.10597 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Diagnosis & Prognosis, online erschienen am 01.11.2026. Verfasst von Dominik Enderlin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University Hospital of Zürich, Zürich, Switzerland. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background/Aim: Reliable biomarkers to stratify prognosis in patients with muscle-invasive bladder cancer (MIBC) undergoing radical cystectomy (RC) remain limited. This study investigated whether the expression of the recently emerging proteins Nectin4 and interferon regulatory factor 6 (IRF6) is associated with pathological stage and oncological survival outcomes in patients undergoing RC for MIBC. Materials and Methods: Two tissue microarrays comprising of 163 patients treated with RC for MIBC were analyzed at the University Hospital of Zürich. Immunohistochemistry was performed for Nectin4 and IRF6, staining intensity was quantified using H-scores. Associations with pathological stage were assessed using logistic regression. Progression-free survival (PFS) and cancer-specific survival (CSS) were evaluated using Cox regression and Kaplan-Meier analysis. Results: Higher Nectin4 and cytoplasmic IRF6 expression were significantly associated with lower pathological T-stage and AJCC stage (p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, University Hospital of Zürich, Zürich, Switzerland.
- Institute of Pathology and Molecular Pathology, University Hospital of Zürich, Zürich, Switzerland.
- Department of Urology, Stadtspital Triemli, Zürich, Switzerland.
Zitieren
APA
Enderlin, D., Gloor, M., Bieri, U., Mazumdar, A., Salemi, S., Rupp, N., Moch, H., Eberli, D., & Poyet, C. (2026). Prognostic Impact of Nectin4 and IRF6 Expression in Patients Undergoing Radical Cystectomy for Muscle-Invasive Bladder Cancer. Cancer Diagnosis & Prognosis, 6(6), 947-960. https://doi.org/10.21873/cdp.10597
Vancouver
Enderlin D, Gloor M, Bieri U, Mazumdar A, Salemi S, Rupp N, et al. Prognostic Impact of Nectin4 and IRF6 Expression in Patients Undergoing Radical Cystectomy for Muscle-Invasive Bladder Cancer. Cancer Diagnosis & Prognosis. 2026;6(6):947-960. doi:10.21873/cdp.10597
BibTeX
@article{Enderlin2026,
author = {Enderlin, Dominik and Gloor, Maria and Bieri, Uwe and Mazumdar, Alekhya and Salemi, Souzan and Rupp, Niels and Moch, Holger and Eberli, Daniel and Poyet, Cédric},
title = {Prognostic Impact of Nectin4 and IRF6 Expression in Patients Undergoing Radical Cystectomy for Muscle-Invasive Bladder Cancer},
journal = {Cancer Diagnosis & Prognosis},
year = {2026},
volume = {6},
number = {6},
pages = {947--960},
doi = {10.21873/cdp.10597}
}
EUVIMED